Genomic Health Reports 7-Fold Revenue Jump in Q2, Increases Full-Year Test Volume, Revenue Estimate | GenomeWeb
Genomic Health this week reported a seven-fold leap in second-quarter revenues, while its net loss fell by 40 percent.
 
The company also updated its full-year revenue guidance to between $24 million and $26 million, from previous expectations of $14 million to $18 million. Net losses are expected to fall between $31 million and $35 million for the year, compared to $37 million to $43 million in previous estimates.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.